Lee, C., Lawler, H., Tan, M., Davis, D., Tong, J., Glodowski, M., . . . Craig, C. (2019). OR20-5 28-Day Dosing with Avexitide Improves Hyperinsulinemic Hypoglycemia in Patients with Severe, Refractory Post-Bariatric Hypoglycemia: The PREVENT Study. J Endocr Soc.
Chicago Style CitationLee, Clare, et al. "OR20-5 28-Day Dosing With Avexitide Improves Hyperinsulinemic Hypoglycemia in Patients With Severe, Refractory Post-Bariatric Hypoglycemia: The PREVENT Study." J Endocr Soc 2019.
Cita MLALee, Clare, et al. "OR20-5 28-Day Dosing With Avexitide Improves Hyperinsulinemic Hypoglycemia in Patients With Severe, Refractory Post-Bariatric Hypoglycemia: The PREVENT Study." J Endocr Soc 2019.
Atenció: Aquestes cites poden no estar 100% correctes.